SC
| |
StemPoint Capital LP13F | |
| StemPoint Capital LP | |
| Last update 2025-05-15 | 61 Stocks (24 new) |
| Value $314.00 Mil | Turnover 42 % |
StemPoint Capital LP Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIV | Roivant Sciences Ltd | 2,578,860 | 26,020.7 | -4.94% | 8.290 | -0.40% | 0.360 | +12.71% | -3.30% | 7,777.0 | Biotechnology | |
SNDX | Syndax Pharmaceuticals Inc | 1,598,594 | 19,638.7 | -44.35% | 6.260 | -4.20% | 1.860 | -18.02% | -28.44% | 814.0 | Biotechnology | |
SRRK | Scholar Rock Holding Corp | 566,212 | 18,203.7 | +240.46% | 5.800 | +4.10% | 0.600 | +32.42% | -5.78% | 3,866.2 | Biotechnology | |
ACLX | Arcellx Inc | 273,774 | 17,959.6 | New Holding | 5.730 | +5.73% | 0.500 | +8.98% | -11.87% | 3,724.7 | Biotechnology | |
MRUS | Merus NV | 346,756 | 14,595.0 | -43.60% | 4.650 | -2.81% | 0.500 | +46.93% | +50.44% | 4,711.4 | Biotechnology | |
IMVT | Immunovant Inc | 853,472 | 14,585.8 | -23.70% | 4.650 | -1.64% | 0.500 | +18.22% | -27.69% | 3,063.8 | Biotechnology | |
MDGL | Madrigal Pharmaceuticals Inc | 40,936 | 13,559.2 | New Holding | 4.320 | +4.32% | 0.180 | +10.76% | +8.28% | 7,418.8 | Biotechnology | |
NUVL | Nuvalent Inc | 190,401 | 13,503.2 | +31.10% | 4.300 | +1.02% | 0.270 | +16.42% | +6.54% | 5,988.9 | Biotechnology | |
RVMD | Revolution Medicines Inc | 318,782 | 11,272.1 | +64.72% | 3.590 | +1.41% | 0.170 | +4.19% | -12.44% | 7,134.0 | Biotechnology | |
JANX | Janux Therapeutics Inc | 342,062 | 9,235.7 | +134.49% | 2.940 | +1.69% | 0.580 | -11.08% | -50.69% | 1,562.2 | Biotechnology |
StemPoint Capital LP's Historical Top Holdings Breakdowns
StemPoint Capital LP's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
ACLX | Arcellx Inc | 2025-03-31 | New Buy New Buy | +5.73% | 60.26 ($67.74) 79.13 | $67.59 | -0.22% | New holding | 273,774 | 273,774 | |
MDGL | Madrigal Pharmaceuticals Inc | 2025-03-31 | New Buy New Buy | +4.32% | 272.79 ($328.59) 355.88 | $334.13 | 1.69% | New holding | 40,936 | 40,936 | |
SNDX | Syndax Pharmaceuticals Inc | 2025-03-31 | Reduce Reduce | -4.20% | 12.29 ($14.1) 16.38 | $9.46 | -32.91% | Reduce -44.35% | 1,598,594 | -1,274,007 | |
SRRK | Scholar Rock Holding Corp | 2025-03-31 | Add Add | +4.10% | 32.15 ($38.47) 46.73 | $40.72 | 5.85% | Add 240.46% | 566,212 | 399,905 | |
CRNX | Crinetics Pharmaceuticals Inc | 2025-03-31 | Sold Out Sold Out | -4.05% | 32.3 ($37.35) 53.15 | $31.11 | -16.71% | Sold Out | 0 | -317,060 | |
INCY | Incyte Corp | 2025-03-31 | Sold Out Sold Out | -3.34% | 60 ($69.73) 75.26 | $67.86 | -2.68% | Sold Out | 0 | -193,623 | |
MRUS | Merus NV | 2025-03-31 | Reduce Reduce | -2.81% | 39.01 ($43.61) 49.16 | $63.26 | 45.06% | Reduce -43.6% | 346,756 | -268,056 | |
PRAX | Praxis Precision Medicines Inc | 2025-03-31 | Sold Out Sold Out | -2.58% | 33.55 ($62.45) 90.77 | $53.85 | -13.77% | Sold Out | 0 | -134,178 | |
RYTM | Rhythm Pharmaceuticals Inc | 2025-03-31 | Reduce Reduce | -2.44% | 48.56 ($55.48) 61.02 | $89.20 | 60.78% | Reduce -83.74% | 33,816 | -174,200 | |
BMY | Bristol-Myers Squibb Co | 2025-03-31 | Sold Out Sold Out | -2.34% | 53.9 ($58.29) 63.11 | $47.36 | -18.75% | Sold Out | 0 | -166,068 |
StemPoint Capital LP Total Holding History ($B)
StemPoint Capital LP's Asset Allocation
StemPoint Capital LP Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
StemPoint Capital LP's Hypothetical Growth since 2025-03-31
StemPoint Capital LP's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
StemPoint Capital LP's Holdings Heat Map
Size field:
StemPoint Capital LP's Holdings Bubble Chart
StemPoint Capital LP News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers